Cardiac Dimensions has a new chief medical officer

Satya Shreenivas. [Image courtesy of Cardiac Dimensions]Cardiac Dimensions announced today that it appointed Dr. Satya Shreenivas as its new chief medical officer (CMO).

Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatments for heart failure with functional mitral regurgitation (FMR). That includes the Carillon Mitral Contour System, for which the company has the ongoing EMPOWER trial. Its new CMO served as an advisor on that trial.

“I’ve seen the compelling clinical evidence on Carillon therapy from Europe and look forward to helping the team expand the supportive body of evidence for this intriguing technology with the U.S. pivotal EMPOWER trial,” said Shreenivas. “I have always been energized by my work with emerging technologies that fill an unmet clinical need and am excited by the opportunity this therapy presents to enhance the lives of heart failure patients in a way that isn’t possible today.”

More about the new CMO at C…
Read more
  • 0

Cardiac Dimensions raises $35M Series D for mitral contour system

The Carillon system. [Image courtesy of Cardiac Dimensions]Heart failure treatment developer Cardiac Dimensions announced today that closed a $35 million Series D financing round.

Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatment modalities for heart failure and related cardiovascular conditions. Its lead product, the Carillon Mitral Contour System, uses a gentle, minimally invasive approach. It designed the system to restore natural mitral valve function without damaging mitral valve leaflets.

According to a news release, the device offers favorable remodeling while reducing mitral regurgitation. Cardiac Dimensions said it improves quality of life and extends survival for a range of patients.

Carillon produces an annuloplasty effect while initiating left ventricular remodeling and improving long-term survival. It can accompany other heart failure treatments if needed, Cardiac Dimensions said.

Existing investor Horiz…

Read more
  • 0